Clinical Trial Update: Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial investigating ST101 for Alzheimer's disease has been completed, reporting preliminary efficacy and safety findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ST101 (ST101)

Snippet

Sponsor: Sonexa Therapeutics, Inc. | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED